Overexpression of Tpl2 is linked to imatinib resistance and activation of <scp>MEK</scp>‐<scp>ERK</scp> and <scp>NF</scp>‐κB pathways in a model of chronic myeloid leukemia

Anna Chorzalska(Brown University), Patrycja M. Dubielecka(New York Blood Center)
Molecular Oncology
February 27, 2018
Cited by 40


Related Papers